Clinical Trials Logo
  1. Home
  2. Cancer of the Esophagus
  3. NCT02415101

Timing of Resective Surgery After Neoadjuvant Chemoradiotherapy in Esophageal Cancer — NeoResII  

Cancer of the Esophagus Clinical Trial

Official title:
Randomized Clinical Trial Comparing the Timing of Resective Surgery After Neoadjuvant Chemoradiotherapy in Cancer of the Esophagus or Gastric Cardia

Clinical Trial Summary

This study compares outcomes with regard to the timing of resective surgery after neoadjuvant chemoradiotherapy (CRT) in cancer of the esophagus or gastric cardia. Patients are randomised to surgery either conventional 4-6 or 10-12 weeks after termination of CRT. The study hypothesis is that a longer delay improves histological response and decreases the risk of postoperative morbidity and mortality.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02415101
Study type Interventional
Source Karolinska University Hospital
Contact
Status Active, not recruiting
Phase N/A
Start date February 2015
Completion date August 2024
View Details
See also
  Status Clinical Trial Phase
Completed NCT00716157 - Incidence and Patterns of Nausea/Vomiting With Combined Chemotherapy and Radiation N/A
Withdrawn NCT04272268 - Feasibility and Safety of Using Nasal High Flow Oxygen Postoperatively to Reduce Respiratory Complications
Terminated NCT03108885 - Measuring Cell Free DNA During the Course of Treatment for Esophageal Cancer as a Marker of Response and Recurrence
Recruiting NCT04046575 - Radiation Dose Intensification With Accelerated Hypofractionated Intensity Modulated Radiation Therapy and Concurrent Carboplatin and Paclitaxel for Inoperable Esophageal Cancer Phase 1
Active, not recruiting NCT00821912 - TaxXel: Taxotere and Xeloda in Esophageal Cancer Phase 1/Phase 2
Completed NCT02642809 - Pembrolizumab With Locally Delivered Radiation Therapy for the Treatment of Metastatic Esophageal Cancers Phase 1
Withdrawn NCT02843750 - Study of Inspiratory Muscle Training for Patients Undergoing Esophageal Surgery N/A
Completed NCT00318903 - Irinotecan and Taxotere With Radiotherapy as Preoperative Treatment in Resectable Esophageal Cancer Phase 2
Completed NCT05688761 - Nordic Gastric and Esophageal Tumor Study
Completed NCT00578071 - Phase I/II Study of Panitumumab, Capecitabine and Oxaliplatin w EBRT for Esophageal Cancer Phase 1/Phase 2
Completed NCT01183559 - A Trial of ZD6474, Paclitaxel, Carboplatin, 5-Fluorouracil, and Radiation Therapy Followed by Surgery Phase 1
Recruiting NCT02530983 - Mayo Clinic Upper Digestive Disease Survey
Active, not recruiting NCT03482791 - Proton Beam Therapy in the Treatment of Esophageal Cancer N/A